1.Gottsch, ML, Cunningham, MJ, Smith, JT, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004; 145:4073–4077.
2.Moreno, I, Codoñer, FM, Vilella, F, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am. J. Obstet. Gynecol. 2016; 215:684–703.
3.Ravel, J, Gajer, P, Abdo, Z, et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U. S. A. 2011; 108(Suppl. 1):4680–4687.
4.Gougeon, A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev. 1996; 17:121–155.
5.Ng, EH, Yeung, WS, Fong, DY, Ho, PC. Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum. Reprod. 2003; 18:2169–2174.
6.Dierich, A, Sairam, MR, Monaco, L, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl. Acad. Sci. U. S. A. 1998; 95:13612–13617.
7.Jayaprakasan, K, Hilwah, N, Kendall, NR, et al. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum. Reprod. 2007; 22:1932–1941.
8.Kumar, TR, Wang, Y, Lu, N, Matzuk, MM. Follicle stimulating hormone is required for ovarian follicle maturation but not for male fertility. Nat. Genet. 1997; 15:201–204.
9.Matthews, CH, Borgato, S, Beck-Peccoz, P, et al. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat. Genet. 1993; 5:83–86.
10.Eppig, J. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001; 122:829–838.
11.Kidder, GM, Mhawi, AA. Gap junctions and ovarian folliculogenesis. Reproduction 2002; 123:613–620.
12.Eppig, JJ, Wigglesworth, K, Pendola, FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc. Natl. Acad. Sci. U. S. A. 2002; 99:2890–2894.
13.Vitt, UA, Hayashi, M, Klein, C, Hsueh, AJW. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol. Reprod. 2000; 62:370–377.
14.Parrott, JA, Skinner, MK. Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 1999; 140:4262–4271.
15.Nilsson, E, Parrott, JA, Skinner, MK. Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis. Mol. Cell. Endocrinol. 2001; 25:123–130.
16.Dissen, GA, Garcia-Rudaz, C, Ojeda, SR. Role of neurotrophic factors in early ovarian development. Semin. Reprod. Med. 2009; 27:24–31.
17.Nilsson, E, Dole, G, Skinner, MK. Neurotrophin NT3 promotes ovarian primordial to primary follicle transition. Reproduction 2009; 138:697–707.
18.Abir, R, Fisch, B, Jin, S, et al. Presence of NGF and its receptors in ovaries from human fetuses and adults. Mol. Hum. Reprod. 2005; 11:229–236.
19.El-Fouly, MA, Cook, B, Nekola, M, Nalbandov, AV. Role of the ovum in follicular luteinization. Endocrinology 1970; 87:286–293.
20.Nekola, MV, Nalbandov, AV. Morphological changes of rat follicular cells as influenced by oocytes. Biol. Reprod. 1971; 4:154–160.
21.Weenen, C, Laven, JSE, von Bergh, ARM, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol. Hum. Reprod. 2004; 10:77–83.
22.Jeppesen, JV, Anderson, RA, Kelsey, TW, et al. Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol. Hum. Reprod. 2013; 19:519–527.
23.Amsterdam, A, Koch, Y, Lieberman, ME, Lindner, HR. Distribution of binding sites for human chorionic gonadotropin in the preovulatory follicle of the rat. J. Cell. Biol. 1975; 67:894–900.
24.Lawrence, TS, Dekel, N, Beers, WH. Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells: a comparative study. Endocrinology 1980; 106:1114–1118.
25.Chen, L, Russell, PT, Larsen, WJ. Functional significance of cumulus expansion in the mouse: roles for the preovulatory synthesis of hyaluronic acid within the cumulus mass. Mol. Reprod. Dev. 1993; 34:87–93.
26.Peng, XR, Hsueh, AJ, LaPolt, PS, Bjersing, L, Ny, T. Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology 1991; 129:3200–3207.
27.Gougeon, A. Rate of follicular growth in the human ovary. In: Rolland, R, Van Hall, EV, Hillier, SG, McNatty, KP, Schoemaker, JS, eds., Follicular Maturation and Ovulation. Amsterdam: Excerpta Medica. 1982; 155–163.
28.McNatty, KP, Hillier, SG, van den Boogaard, AMJ, et al. Follicular development during the luteal phase of the human menstrual cycle. J. Clin. Endocrinol. Metab. 1983; 56:1022–1031.
29.Pache, TD, Wladimiroff, JW, de Jong, FH, Hop, WC, Fauser, BCJM. Growth patterns of non dominant ovarian follicles during the normal menstrual cycle. Fertil. Steril. 1990; 54:638–642.
30.Gougeon, A, Lefèvre, B. Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle. J. Reprod. Fert. 1983; 69:497–502.
31.Kobayashi, M, Nakano, R, Ooshima, A. Immunocytochemical localization of pituitary gonadotrophins and gonadal steroids confirms the ‘two-cell, two-gonadotrophin’ hypothesis of steroidogenesis in the human ovary. J. Endocrinol. 1990; 126:483–488.
32.Soules, MR, Steiner, RA, Clifton, DK, et al. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J. Clin. Endocrinol. Metab. 1984; 58:378–383.
33.Crowley, WF, McArthur, JW. Simulations of the normal menstrual cycle in Kallmann’s syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J. Clin. Endocrinol. Metab. 1980; 51:173–175.
34.Solovyeva, EV, Hayashi, M, Margi, K, et al. Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol. Reprod. 2000; 63:1214–1218.
35.Dunlop, CE, Anderson, RA. The regulation and assessment of follicular growth. Scand. J. Clin. Lab. Invest. Suppl. 2014; 244:13–17.
36.Donez, J, Squifflet, J, Jadoul, P, et al. Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil. Steril. 1987; 2011:e1-e4.
37.Choi, J. Smitz, J. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol. Cell. Endocrinol. 2014; 383:203–213.
38.Casarini, L, Lispi, M, Longobardi, S, et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signaling. PLoS One 2012; 7, e46682.
39.Wide, L, Bakos, O. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase. J. Clin. Endocrinol. Metab. 1993; 76:885–889.
40.McNatty, KP. Ovarian follicular development from the onset of luteal regression in humans and sheep. In: Rolland, R, Van Hall, EV, Hillier, SG, McNatty, KP, Schoemaker, JS, eds., Follicular Maturation and Ovulation. Amsterdam: Excerpta Medica. 1982; 1–18.
41.Liu, L, Kong, N, Xia, G, Zhang, M. Molecular control of oocyte meiotic arrest and resumption. Reprod. Fertil. Dev. 2013; 25:463–471.
42.Reddy, P, Adhikari, D, Zheng, W, et al. PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles. Hum. Mol. Genet. 2009; 18:2813–2824.
43.Meduri, G, Charnaux, N, Driancourt, MA, et al. Follicle-stimulating hormone receptors in oocytes? J. Clin. Endocrinol. Metab. 2002; 87:2266–2276.
44.Patsoula, E, Loutradis, D, Drakakis, P, et al. Messenger RNA expression for the follicle-stimulating hormone receptor and luteinizing hormone receptor in human oocytes and pre-implantation-stage embryos. Fertil. Steril. 2003; 79:1187–1193.
45.Otsuka, F, Shimasaki, S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc. Natl. Acad. Sci. U. S. A. 2002; 99:8060–8065.
46.Lefievre, L, Conner, SJ, Salpekar, A, et al. Four zona pellucida glycoproteins are expressed in the human. Hum. Reprod. 2004; 19:1580–1586.
47.Motta, PM, Makabe, S, Naguro, T, Correr, S. Oocyte follicle cells association during development of human ovarian follicle. A study by high resolution scanning and transmission electron microscopy. Arch. Histol. Cytol. 1994; 57:369–394.
48.Bergh, C, Olsson, JH, Selleskog, U, Hillensjo, T. Steroid production in cultured thecal cell obtained from human ovarian follicles. Hum. Reprod. 1993; 8:519–524.
49.Gilling-Smith, C, Franks, S. Ovarian function in assisted reproduction. In: Leung, PC, Adashi, EY, eds., The Ovary, 2nd ed. San Diego: Elsevier Academic Press. 2004; 473–488.
50.Gougeon, A. Steroid 3β-ol-dehydrogenase activity in the largest healthy and atretic follicles in the human ovary during the menstrual cycle. Ann. Biol. Anim. Biochim. Biophys. 1977; 17:1087–1094.
51.Curtis, EM. Normal ovarian histology in infancy and childhood. Obstet. Gynecol. 1962; 19:444–454.
52.Dekel, N, David, MP, Yedwab, GA, Kraicer, PF. Follicular development during late pregnancy. Int. J. Fertil. 1977; 22:24–29.
53.Bloom, W, Fawcett, DW. A Textbook of Histology, 10th ed. Philadelphia: Saunders. 1975.
54.Amsterdam, A, Rotmensch, S. Structure-function relationships during granulosa cell differentiation. Endocr. Rev. 1987; 8:309–337.
55.Hillier, SG, Yong, EL, Illingworth, PJ, et al. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol. Cell. Endocrinol. 1991; 75:R1–R6.
56.Roberts, VJ, Barth, S, El-Roeiy, A, Yen, SSC. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J. Clin. Endocrinol. Metab. 1993; 77:1402–1410.
57.Sasano, H, Okamoto, M, Mason, JI, et al. Immunolocalization of aromatase, 17ɑ-hydroxylase and side-chain cleavage cytochrome P-450 in the human ovary. J. Reprod. Fertil. 1989; 85:163–169.
58.Hernandez, ER, Hurwitz, A, Vera, A, et al. Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary. J. Clin. Endocrinol. Metab. 1992; 74:419–425.
59.Salas, C, Julio-Pieper, M, Valladares, M, et al. Nerve growth factor-dependent activation of trkA receptors in the human ovary results in synthesis of follicle-stimulating hormone receptors and estrogen secretion. J. Clin. Endocrinol. Metab. 2006; 91:2396–2403.
60.Shima, K, Kitayama, S, Nakano, R. Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet. Gynecol. 1987; 69:800–806.
61.McNatty, KP, Makris, A, DeGrazia, C, Osathanondh, R, Rayan, KJ. The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J. Clin. Endocrinol. Metab. 1979; 49:687–699.
62.McNatty, KP, Smith, DM, Makris, A, Osathanondh, R, Ryan, KJ. The microenvironment of the human antral follicle: interrelationship among the steroid levels in antral fluid, the population of granulosa cells and the status of the oocyte in vivo and in vitro. J. Clin. Endocrinol. Metab. 1979; 49:851–860.
63.Hillier, SG. Intrafollicular paracrine function of ovarian androgen. J. Steroid. Biochem. 1987; 27:351–357.
64.Zeleznik, AJ, Schuler, HM, Reichert, LE. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 1981; 109:356–362.
65.Wulff, C, Wiegand, SJ, Saunders, PT, Scobie, GA, Fraser, HM. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap[A40]). Endocrinology 2001; 142:3244–3254.
66.Pauerstein, CJ, Eddy, CA, Croxatto, HD, et al. Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infra-human primates. Am. J. Obstet. Gynecol. 1978; 130:876–886.
67.Park, SJ, Goldsmith, LT, Skurnick, JH, Wojtczuk, A, Weiss, G. Characteristics of the urinary luteinizing hormone surge in young ovulatory women. Fertil. Steril. 2007; 88:684–690.
68.Direito, A, Bailly, S, Mariani, A, Ecochard, R. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Fertil. Steril. 2012; 99:279–285.
69.Alliende, ME. Luteinizing hormone surge in normally ovulating women. Fertil. Steril. 2013; 99:e14–e15.
70.Yussman, MA, Taymor, MI, Miyata, J, Pheteplace, C. Serum levels of follicle-stimulating hormone, luteinizing hormone, and plasma progestins correlated with human ovulation. Fertil. Steril. 1970; 21:119–125.
71.Kerin, J. Ovulation detection in the human. Clin. Reprod. Fertil. 1982; 1:27–54.
72.Richards, JS, Russell, DL, Ochsner, S, Espey, LL. Ovulation: new dimensions and new regulators of the inflammatory-like response. Ann. Rev. Physiol. 2002; 64:69–92.
73.Okamura, H, Okazaki, T, Nakajima, A. Effects of electrical stimulation on human ovarian contractility. Obstet. Gynecol. 1975; 45:557–561.
74.Okamura, H, Takenaka, A, Yajima, Y, Nishimura, T. Ovulatory changes in the wall at the apex of the human Graafian follicle. J. Reprod. Fertil. 1980; 58:153–155.
75.Duffy, DM. Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway. Hum. Reprod. Update 2015; 21:652–670.
76.Priddy, AR, Killick, SR, Elstein, M, et al. Ovarian follicular fluid eicosanoid concentrations during the pre-ovulatory period in humans. Prostaglandins 1989; 38:197–202.
77.Duffy, DM, Stouffer, RL. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol. Hum. Reprod. 2001; 7:731–739.
78.Tjugum, J, Norström, A, Dennefors, B, Lundin, S. Oxytocin in human follicular fluid and its possible role in the ovulatory process as studied in vitro. Hum. Reprod. 1986; 1:283286.
79.Meidan, R, Altstein, M, Girsh, E. Biosynthesis and release of oxytocin by granulosa cells derived from preovulatory bovine follicles: effects of forskolin and insulin-like growth factor-I. Biol. Reprod. 1992; 46:715–720.
80.Horka, P, Malickova, K, Jarosova, R, et al. Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization. J. Assist. Reprod. Genet. 2012; 29:1207–1212.
81.Hernandez-Gonzalez, I, Gonzalez-Robayna, I, Shimada, M, et al. Gene expression profiles of cumulus cell oocyte complexes during ovulation reveal cumulus cells express neuronal and immune-related genes: does this expand their role in the ovulation process? Mol. Endocrinol. 2006; 20:1300–1321.
82.Edson, MA, Nagaraja, AK, Matzuk, MM. The mammalian ovary from genesis to revelation. Endocr. Rev. 2009; 30:624–712.
83.Gershon, E, Plaks, V, Dekel, N. Gap junctions in the ovary: expression, localization and function. Mol. Cell. Endocrinol. 2008; 282:18–25.
84.Freimann, S, Ben-Ami, I, Dantes, A, Ron-El, R, Amsterdam, A. EGF-like factor epiregulin and amphiregulin expression is regulated by gonadotropins/cAMP in human ovarian follicular cells. Biochem. Biophys. Res. Commun. 2004; 324:829–834.
85.Park, JY, Su, YQ, Ariga, M, et al. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004; 303:682–684.
86.Hizaki, H, Segi, E, Sugimoto, Y, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc. Natl. Acad. Sci. U. S. A. 1999; 96:10501–10506.
87.Gueripel, X, Brun, V, Gougeon, A. Oocyte bone morphogenetic protein 15, but not growth differentiation factor 9, is increased during gonadotropin-induced follicular development in the immature mouse and is associated with cumulus oophorus expansion. Biol. Reprod. 2006; 75:836–843.
88.Elvin, JA, Yan, C, Matzuk, MM. Oocyte-expressed TGF-beta superfamily members in female fertility. Mol. Cell. Endocrinol. 2000; 159:1–5.
89.Maruo, T, Katayama, K, Barnea, ER, Mochizuki, M. A role for thyroid hormone in the induction of ovulation and corpus luteum function. Horm. Res. 1992; 37 (Suppl. 1):12–18.
90.Chaffkin, LM, Luciano, AA, Peluso, JJ. Progesterone as an autocrine/paracrine regulator of human granulosa cell proliferation. J. Clin. Endocrinol. Metab. 1992; 75:1404–1408.
91.Sasano, H, Mori, T, Sasano, N, Nagura, H, Mason, JI. Immunolocalization of 3beta-hydroxysteroid dehydrogenase in human ovary. J. Reprod. Fertil. 1990; 89:743–751.
92.Brezinka, C. 3D ultrasound imaging of the human corpus luteum. Reprod. Biol. 2014; 14:110–114.
93.Jokubkiene, L, Sladkevičius, P, Rovas, L, Valentin, L. Assessment of changes in volume and vascularity of the ovaries during the normal menstrual cycle using three dimentional power Doppler ultrasound. Hum. Reprod. 2006; 21:2661–2668.
94.Stouffer, RL, Bishop, CV, Bogan, RL, Xu, F, Hennebold, JD. Endocrine and local control of the primate corpus luteum. Reprod. Biol. 2013; 13:259–271.
95.Nishimori, K, Dunkel, L, Hsueh, A, Yamoto, M, Nakano, R. Expression of luteinizing hormone and chorionic gonadotropin receptor messenger ribonucleic acid in human corpora lutea during menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab. 1995; 80:1444–1448.
96.Crisp, TM, Dessouky, DA, Denys, FR. The fine structure of the human corpus luteum of early pregnancy and during the progestational phase of menstrual cycle. Am. J. Anat. 1970; 127:37–69.
97.Meidan, R, Girsh, E, Blum, O, Aberdam, E. In vitro differentiation of bovine theca and granulosa cells into small and large luteal-like cells: morphological and functional characteristics. Biol. Reprod. 1990; 43:913–921.
98.Sanders, SL, Stouffer, RL. Localization of steroidogenic enzymes in macaque luteal tissue during the menstrual cycle and simulated early pregnancy: immunohistochemical evidence supporting the two-cell model for estrogen production in the primate corpus luteum. Biol. Reprod. 1997; 56:1077–1087.
99.Reynolds, L, Redmer, D. Growth and development of the corpus luteum. J. Reprod. Fertil. Suppl. 1999; 54:181–191.
100.Robinson, RS, Woad, KJ, Hammond, AJ, et al. Angiogenesis and vascular function in the ovary. Reproduction 2009; 138:869–881.
101.Ferrara, N, Chen, H, Davis-Smyth, T, et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 1998; 4:336–340.
102.Wulff, C, Dickson, SE, Duncan, WC, Fraser, HM. Angiogenesis in the human corpus luteum: simulated early pregnancy by hCG treatment is associated with both angiogenesis and vessel stabilization. Hum. Reprod. 2001; 16:2515–2524.
103.Forsythe, JA, Jiang, BH, Iyer, NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996; 16:4604–4613.
104.Fraser, HM, Duncan, WC. Regulation and manipulation of angiogenesis in the ovary and endometrium. Reprod. Fertil. Dev. 2009; 21:277–392.
105.Spencer, TE, Bazer, FW. Conceptus signals for establishment and maintenance of pregnancy. Reprod. Biol. Endocrinol. 2004; 2:49.
106.Horton, EW, Poyser, NL. Uterine luteolytic hormone: a physiological role of prostaglandin F2α. Physiol. Rev. 1976; 56:595–651.
107.Miyamoto, A, Shirasuna, K, Shimizu, T, Bollwein, H, Schams, D. Regulation of corpus luteum development and maintenance: specific roles of angiogenesis and action of prostaglandin F2α. Soc. Reprod. Fertil. Suppl. 2010; 67:289–304.
108.Best, CL, Pudney, J, Welch, WR, Burger, N, Hill, JA. Localization and characterization of white blood cell populations within the human ovary throughout the menstrual cycle and menopause. Hum. Reprod. 1996; 11:790–797.
109.Townson, DH, Liptak, AR. Chemokines in the corpus luteum: implications of leukocyte chemotaxis. Reprod. Biol. Endocrinol. 2003; 1:94.
110.Girsh, E, Milvae, RA, Wang, W, Meidan, R. Effect of endothelin-1 on bovine luteal cell function: role in prostaglandin F2a-induced antisteroidogenic action. Endocrinology 1996; 137:1306–1312.
111.Wulff, C, Wilson, H, Largue, P, et al. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J. Clin. Endocrinol. Metab. 2000; 85:4302–4309.
112.Zalman, Y, Klipper, E, Farberov, S, et al. Regulation of angiogenesis-related prostaglandin F2α-induced genes in the bovine corpus luteum. Biol. Reprod. 2012; 86:92.
113.Farberov, S, Meidan, R. Thrombospondin-1 affects bovine luteal function via transforming growth factor β1-dependent and independent actions. Biol. Reprod. 2016; 94:25.
114.Yadav, VK, Lakshmi, G, Medhamurthy, R. Prostaglandin F2α-mediated activation of apoptotic signaling cascades in the corpus luteum during apoptosis: involvement of caspase-activated DNase. J. Biol. Chem. 2005; 280:10357–10367.
115.Duncan, WC, McNeilly, AS, Fraser, HM, Illingworth, PJ. Luteinizing hormone receptor in the human corpus luteum: lack of down regulation during maternal recognition of pregnancy. Hum. Reprod. 1996; 11:2291–2297.
116.Jabbour, HN, Kelly, RW, Fraser, HM, Critchley, HO. Endocrine regulation of menstruation. Endocr. Rev. 2006; 27:17–46.
117.Nagaoka, SI, Hassold, TJ, Hunt, PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat. Rev. Genet. 2012; 13:493–504.
118.Huang, L, Tong, X, Luo, L, et al. Mutation analysis of the TUBB8 gene in nine infertile women with oocyte maturation arrest. RBM Online 2017; 35:305–310.
119.American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Age-related fertility decline. Obstet. Gynecol. 2008; 112:409–411.
120.Ziebe, S, Devroey, P. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum. Reprod. Update. 2008; 14:583–592.
121.Menken, J, Trussell, J, Larsen, U. Age and infertility. Science 1986; 233:1389–1394.
122.Faddy, MJ, Gosden, RG, Gougeon, A, Richardson, SJ, Nelson, JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 1992; 7:1342–1346.
123.Rosen, MP, Johnstone, E, McCulloch, CE, et al. A characterization of the relationship of ovarian reserve markers with age. Fertil. Steril. 2012; 97:238–243.
124.Hansen, KR, Knowlton, NS, Thyer, AC, et al. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum. Reprod. 2008; 23:699–708.
125.Wang, YA, Dean, J, Badgery-Parker, T, Sullivan, EA. Assisted Reproduction Technology in Australia and New Zealand 2006. Sydney: AIHW National Peritnatal Statistics Unit. 2008.
126.Fitzgerald, O, Paul, RC, Harris, K, Chambers, GM. Assisted Reproductive Technology in Australia and New Zealand 2016. Sydney: National Perinatal Epidemiology and Statistics Unit, the Univeristy of New South Wales Sydney. 2018.
127.Gilbert, WM, Nesbitt, TS, Danielsen, B. Childbearing beyond age 40: pregnancy outcome in 24,032 cases. Obstet. Gynecol. 1999; 93:9–14.
128.Meng, L, Jan, SZ, Hamer, G, et al. Preantral follicular atresia occurs mainly through autophagy, while antral follicles degenerate mostly through apoptosis. Biol. Reprod. 2018; 99:853–863.
129.Baker, TG. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. Lond. B. Biol. Sci. 1963;158:417–433.
130.Richardson, SJ, Senikas, V, Nelson, JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J. Clin. Endocrinol. Metab. 1987; 65:1231–1237.
131.Murray, A, Schoemaker, MJ, Bennett, CE, et al. Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet. Med. 2014; 16:19–24.
132.Broekmans, FJ, Soules, MR, Fauser, BC. Ovarian aging: mechanisms and clinical consequences. Endocr. Rev. 2009; 30:465–493.
133.Johnson, NP, Bagrie, EM, Coomarasamy, A, et al. Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy. BJOG 2006; 113:1472–1480.
134.te Velde, ER, Pearson, PL. The variability of female reproductive ageing. Hum. Reprod. Update 2002; 8:141–154.
135.Klein, NA, Battaglia, DE, Miller, PB, et al. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J. Clin. Endocrinol. Metab. 1996; 81:1946–1951.
136.Burger, HG, Hale, GE, Dennerstein, L, Robertson, DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008; 15:603–612.
137.Klein, NA, Battaglia, DE, Fujimoto, VY, et al. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J. Clin. Endocrinol. Metab. 1996; 81:1038–1045.
138.Rossmanith, WG. Gonadotropin secretion during aging in women. Exp. Gerontology 1995; 30:369–381.
139.de Bruin, JP, Bovenhuis, H, van Noord, PA, et al. The role of genetic factors in age at natural menopause. Hum. Reprod. 2001; 16:2014–2018.
140.van Asselt, KM, Kok, HS, Pearson, PL, et al. Heritability of menopausal age in mothers and daughters. Fertil. Steril. 2004; 82:1348–1351.
141.Kalmbach, KH, Antunes, DM, Kohlrausch, F, Keefe, DL. Telomeres and female reproductive aging. Semin. Reprod. Med. 2015; 33:389–395.
142.Keefe, DL, Marquard, K, Liu, L. The telomere theory of reproductive senescence in women. Curr. Opin. Obstet. Gynecol. 2006; 18:280–285.
143.Keefe, DL. Telomeres, reproductive aging, and genomic instability during early development. Reprod. Sci. 2016; 23:1612–1615.
144.Westhoff, C, Murphy, P, Heller, D. Predictors of ovarian follicle number. Fertil. Steril. 2000; 74:624–628.
145.Stock, D, Knight, JA, Raboud, J, et al. Rotating night shift work and menopausal age. Hum. Reprod. 2019; 34:539–548.
146.Pellestor, F, Andreo, B, Arnal, F, Humeau, C, Demaille, J. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum. Genet. 2003; 112:195–203.
147.Alberman, E, Creasy, M, Elleott, M, Spicier, C. Maternal factors associated with fetal chromosomal anomalies in spontaneous abortions. Br. J. Obstet. Gynecol. 1976; 83:621–627.
148.Volarcik, K, Sheean, L, Goldfarb, J, et al. The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum. Reprod. 1998; 13:154–160.
149.Yun, Y, Holt, JE, Lane, SI, et al. Reduced ability to recover from spindle disruption and loss of kinetochore spindle assembly checkpoint proteins in oocytes from aged mice. Cell Cycle 2014; 13:1938–1947.
150.Hassold, T, Hunt, P. To err (meiotically) is human: the genesis of human aneuploidy. Nat. Rev. Genet. 2001; 2:280–291.
151.Chiang, T, Duncan, FE, Schindler, K, Schultz, RM, Lampson, MA. Evidence that weakened centromere cohesion is a leading cause of age-related aneuploidy in oocytes. Curr. Biol. 2010; 20:1522–1528.
152.Cheng, JM, Liu, YX. Age-related loss of cohesion: causes and effects. Int. J. Mol. Sci. 2017; 18. doi:10.3390/ijms18071578.
153.Kuliev, A, Verlinsky, Y. Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum. Reprod. Update 2004; 10:401–407.
154.Nagaoka, SI, Hassold, TJ, Hunt, PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat. Rev. Genet. 2012; 13:493–504.
155.May-Panloup, P, Boucret, L, Chao de la Barca, JM, et al. Ovarian ageing: the role of mitochondria in oocytes and follicles. Hum. Reprod. Update 2016; 22:725–743.
156.Broekmans, FJ, Faddy, MJ, Scheffer, G, te Velde, ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 2004; 11:607–614.
157.Tietze, C. Fertility after discontinuation of intrauterine and oral contraception. Int. J. Fertil. 1968; 13:385–389.
158.Gunby, J, Bissonnette F, , Librach, C, Cowan, L; IVF Directors Group of the Canadian Fertility and Andrology Society. Assisted reproductive technologies (ART) in Canada: 2006 results from the Canadian ART Register. Fertil. Steril. 2010; 93:2189–2201.
159.Noci, I, Borri, P, Chieffi, O, et al. Aging of the human endometrium: a basic morphological and immunohistochemical study. Eur. J. Obstet. Gynecol. Reprod. Biol. 1995; 63:181–185.
160.Wang, YA, Farquhar, C, Sullivan, EA. Donor age is a major determinant of success of oocyte donation/recipient programme. Hum. Reprod. 2012; 27:118-125.
161.Sherman, BM, West, JH, Korenman, SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metab. 1976; 42:629–636.
162.Sabatini, L, Zosmer, A, Hennessy, EM, Tozer, A, Al-Shawaf, T. Relevance of basal serum FSH to IVF outcome varies with patient age. RBM Online 2008; 17:10–19.
163.Broekmans, FJ, de Ziegler, D, Howles, CM, et al. The antral follicle count: practical recommendations for better standardization. Fertil. Steril. 2010; 94:1044–1051.
164.Broekmans, FJ, Kwee, J, Hendriks, DJ, Mol, BW, Lambalk, CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update 2006; 12:685–718.
165.La Marca, A, Volpe, A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin. Endocrinol. 2006; 64:603–610.
166.Li, HWR, Yeung, WSB, Lau, EYL, Ho, PC, Ng, EHY. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil. Steril. 2010; 94:2177–2181.
167.Hehenkamp, WJ, Looman, CW, Themmen, AP, et al. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J. Clin. Endocrinol. Metab. 2006; 91:4057–4063.
168.Sowers, MR, Eyvazzadeh, AD, McConnell, D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 2008; 93:3478–3483.
169.Broekmans, FJ. Testing for ovarian reserve in assisted reproduction programs: the current point of view. Fact Views Vis. Obgin. 2009; 1:79–81.